IBO
AMEX · Pharmaceuticals
Impact Biomedical Inc
$0.65
-0.13 (-17.08%)
Open$0.59
Previous Close$0.78
Day High$0.69
Day Low$0.58
52W High$6.17
52W Low$0.36
Volume—
Avg Volume1.17M
Market Cap48.44M
P/E Ratio—
EPS$-3.58
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.01M | 2.09M | 2.10M |
| Net Income | 252.5K | 255.6K | 224.6K |
| Profit Margin | 12.5% | 12.2% | 10.7% |
| EBITDA | 413.4K | 402.4K | 414.7K |
| Free Cash Flow | 302.8K | 206.2K | 229.1K |
| Rev Growth | +12.9% | +6.5% | +8.3% |
| Debt/Equity | 0.52 | 0.58 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |